CLINICAL_TRIALS
trial_result
· 2021-04-30
Clinical Trial Update: Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer [Phase 1]
Summary
Phase 1 safety study of selinexor (KPT-330) in advanced or metastatic solid tumors has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Karyopharm Therapeutics Inc | Conditions: Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2021-04-30